Latest News

DARRT-1 study advancing on basis of positive clinical data
NOX announces Positive Data from CEP-1 Study of Veyonda
NOX 2018 AGM Presentations
NOX to Present Clinical Data at COSA Annual Meeting
Corporate Presentation
NOX makes key executive appointment
Noxopharm Releases Report on Key Progress of Subsidiary
Annual Report to shareholders
NOX Subsidiary Announces Important Drug Discovery
NOX to support expanded LuPIN study